Detection of Endocrine Responsiveness by Flow Cytometric DNA Analysis in Experimental Human Breast Cancer

  • N. Brünner
  • M. Spang-Thomsen
  • L. Vindeløv
  • A. Nielsen
  • S. A. Engelholm
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 90)


In human metastatic breast cancer, the response to endocrine therapy is approximately 30%, regardless of type of endocrine therapy applied (McGuire et al. 1975). Mainly based on this observation, it has been suggested that different kinds of endocrine treatment share the same ultimate mode of action (Rose 1982). However, in recent years it has been shown that different endocrine treatment modalities do not always show cross-resistance (Smith et al. 1982, Murray and Pitt 1982), suggesting different modes of action.


Nude Mouse Human Breast Cancer Endocrine Treatment Human Breast Carcinoma Amino Glutethimide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brünner N, Spang-Thomsen M, Vindeløv L, Nielsen A (1983) Effect of 17 β-oestradiol on growth curves and flow cytometric DNA distribution of two human breast carcinomas grown in nude mice. Br J Cancer 47: 641PubMedCrossRefGoogle Scholar
  2. 2.
    Christensen IJ, Hartmann NR, Keiding N, Larsen JK, Noer H, Vindeløv L (1978) Statistical analysis of DNA distributions from cell populations with partial synchrony. In: Lutz D (ed) Pulse-Cytometry, vol 3. Euroean Press Medicon, Ghent, p 71Google Scholar
  3. 3.
    Israel N, Saez S (1978) Relation between steroid receptor content and the response to hormone addition in isolated human breast cancer cells in short-term culture. Cancer Res 38:4314PubMedGoogle Scholar
  4. 4.
    McGuire WL, Carbone PP, Sears ME, Escher GC (1975) Estrogen receptors in human breast cancer: an overview. In: McGuire WL, Carbone PP, Volmer EP (eds) Estrogen receptors in human breast cancer. Raven New York, p 1Google Scholar
  5. 5.
    Miller WR, Forrest APM (1974) Oestradiol synthesis by a human breast carcinoma. Lancet 2:866PubMedCrossRefGoogle Scholar
  6. 6.
    Miller WR, Hawkins RA, Forrest APM (1982) Significance of Aromastase Activity in Human Breast Cancer. Cancer Res (Suppl) 42:3365Google Scholar
  7. 7.
    Murray RML, Pitt P (1982) Aminoglutethimide in tamoxifen-resistant patients: The Melbourne experience. Cancer Res (Suppl) 42:3437Google Scholar
  8. 8.
    Osborne CK, Yochmowitz MG, Knight WA, McGuire WL (1980) The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46:2884PubMedCrossRefGoogle Scholar
  9. 9.
    Perel E, Blackstein ME, Killinger DW (1982) Aromastase in human breast carcinoma. Cancer Res (Suppl) 42: 3369Google Scholar
  10. 10.
    Poulsen HS, Bichel P, Andersen J (1982) Short-term culture of human breast cancer: In vitro effects of hormones related to patient response. Br J Cancer 46:67PubMedCrossRefGoogle Scholar
  11. 11.
    Rose DP (1982) Postmenopausal oestrogen production and its inhibition. In: Stoll BA (ed) Endocrine relationships in breast cancer. Heinemann Medical, London, p 187Google Scholar
  12. 12.
    Sanfilippo O, Daidone MG, Di Fronzo G, Silvestrini R (1979) Short-term tissue culture of human breast cancer. Cancer 43: 2365PubMedCrossRefGoogle Scholar
  13. 13.
    Smith IE, Harris AL, Morgan M, Gazet J-C, McKinna JA (1982) Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the reatment of advanced breast carcinoma. Cancer Res (Suppl) 42:3430Google Scholar
  14. 14.
    Spang-Thomsen M, Nielsen A, Visfeldt J (1980) Growth curves of three human malignant tumors transplanted to nude mice. Exp Cell Biol 48:138PubMedGoogle Scholar
  15. 15.
    Spang-Thomsen M, Visfeldt J, Nielsen A (1981) Effect of single-dose x-irradiation on the growth curves of a human malignant melanoma transplanted into nude mice. Radiat Res 85:184PubMedCrossRefGoogle Scholar
  16. 16.
    Vindeløv L (1977) Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Virchows Arch [Cell Pathol] 24:227Google Scholar
  17. 17.
    Vindeløv L, Christensen IJ, Keiding N, Spang-Thomsen M, Nissen NI (1983a) Long-term storage of samples for flow cytometric DNA analysis. Cytometry 3:31Google Scholar
  18. 18.
    Vindeløv L, Christensen IJ, Nissen NI (1983b) A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • N. Brünner
    • 1
  • M. Spang-Thomsen
    • 1
  • L. Vindeløv
    • 1
  • A. Nielsen
    • 1
  • S. A. Engelholm
    • 1
  1. 1.The University Institute of Pathological AnatomyUniversity of CopenhagenCopenhagenDenmark

Personalised recommendations